Cadrenal Therapeutics, Inc. (CVKD) SEC filings
CVKD SEC filings moved a median of -0.54% by the close. CVKD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CVKD overview →
96 measured CVKD SEC filing events.
Where these CVKD SEC filings landedvs 95 measured CVKD SEC filing reactions
| Middle 50% of CVKD SEC filing reactions | -3.95% to +2.71% |
|---|---|
| Median reaction (to close) | -0.54% |
| Measured reactions | 95 |
Point-in-time · zero look-ahead
Half of the 95 CVKD SEC filing events with a measured close landed between -3.95% and +2.71%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 Cadrenal Therapeutics, | SEC filing · Form S-8 | -3.79% | -6.56% | |
| Form 8-K Cadrenal Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -6.50% | -3.73% | |
| Form 8-K Cadrenal Therapeutics, For: Sep 24 | SEC filing · Form 8-K | +0.00% | -1.82% | |
| Form S-8 Cadrenal Therapeutics, | SEC filing · Form S-8 | +0.79% | -3.17% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 31 | SEC filing · Form 8-K | -5.49% | +6.71% | |
| Form 10-Q Cadrenal Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.53% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +0.00% | -0.53% | |
| Form ARS Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +3.57% | |
| Form DEF 14A Cadrenal Therapeutics, For: Sep 24 | SEC filing · Form DEF | +0.00% | +3.57% | |
| Form DEFA14A Cadrenal Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +3.57% | |
| Form PRE 14A Cadrenal Therapeutics, For: Jul 23 | SEC filing · Form PRE | -0.49% | -0.49% | |
| Form 8-K Cadrenal Therapeutics, For: Jul 21 | SEC filing · Form 8-K | -0.47% | +1.40% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | -0.47% | +1.40% | |
| Form 8-K Cadrenal Therapeutics, For: Jul 14 | SEC filing · Form 8-K | +2.73% | -5.00% | |
| Form D Cadrenal Therapeutics, | SEC filing · Form D | +0.00% | -2.10% | |
| Form S-3 Cadrenal Therapeutics, | SEC filing · Form S-3 | -1.25% | +0.41% | |
| Form 8-K Cadrenal Therapeutics, For: Jul 07 | SEC filing · Form 8-K | -10.88% | -21.43% | |
| Form 8-K Cadrenal Therapeutics, For: Jun 30 | SEC filing · Form 8-K | +1.94% | +16.50% | |
| Form 8-K Cadrenal Therapeutics, For: Jun 25 | SEC filing · Form 8-K | +1.01% | +12.46% | |
| Form 8-K Cadrenal Therapeutics, For: Jun 18 | SEC filing · Form 8-K | +2.06% | +7.36% | |
| Form 8-K Cadrenal Therapeutics, For: May 28 | SEC filing · Form 8-K | +6.21% | +2.86% | |
| Form 10-Q Cadrenal Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.53% | -2.75% | |
| Form 8-K Cadrenal Therapeutics, For: May 07 | SEC filing · Form 8-K | +1.53% | -2.75% | |
| Form 8-K Cadrenal Therapeutics, For: Apr 30 | SEC filing · Form 8-K | +0.00% | +21.94% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | +0.00% | +21.94% | |
| Form S-3 Cadrenal Therapeutics, | SEC filing · Form S-3 | +1.82% | +3.26% | |
| Form D Cadrenal Therapeutics, | SEC filing · Form D | +0.00% | -4.00% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 31 | SEC filing · Form 8-K | +0.00% | -4.67% | |
| Form 10-K Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.00% | +18.25% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 31 | SEC filing · Form 8-K | +3.00% | +18.25% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 12 | SEC filing · Form 8-K | +1.69% | -6.75% | |
| Form 8-K Cadrenal Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +1.61% | +14.06% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | -1.74% | -1.87% | |
| Form D Cadrenal Therapeutics, | SEC filing · Form D | -1.74% | -1.87% | |
| Form S-1 Cadrenal Therapeutics, | SEC filing · Form S-1 | +0.00% | -6.24% | |
| Form 8-K Cadrenal Therapeutics, For: Dec 23 | SEC filing · Form 8-K | +3.87% | +5.74% | |
| Form 8-K Cadrenal Therapeutics, For: Dec 15 | SEC filing · Form 8-K | -4.48% | -13.97% | |
| Form 8-K Cadrenal Therapeutics, For: Dec 10 | SEC filing · Form 8-K | -1.11% | -8.33% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 24 | SEC filing · Form 8-K | +0.00% | -0.55% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 18 | SEC filing · Form 8-K | -0.17% | -5.06% | |
| Form 10-Q Cadrenal Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.82% | +2.17% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +3.82% | +2.17% | |
| Form 8-K Cadrenal Therapeutics, For: Sep 24 | SEC filing · Form 8-K | +0.29% | +2.82% | |
| Form 8-K Cadrenal Therapeutics, For: Sep 12 | SEC filing · Form 8-K | +0.00% | +0.07% | |
| Form 10-Q Cadrenal Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.18% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -1.32% | — | |
| Form 8-K Cadrenal Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +4.10% | +13.54% | |
| Form ARS Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | -0.76% | |
| Form DEF 14A Cadrenal Therapeutics, For: Sep 24 | SEC filing · Form DEF | +0.00% | -0.76% | |
| Form DEFA14A Cadrenal Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -0.76% | |
| Form 8-K Cadrenal Therapeutics, For: Jul 15 | SEC filing · Form 8-K | +0.00% | -2.84% | |
| Form 10-Q Cadrenal Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.06% | |
| Form 8-K Cadrenal Therapeutics, For: May 08 | SEC filing · Form 8-K | -0.47% | -9.52% | |
| Form 8-K Cadrenal Therapeutics, For: Apr 17 | SEC filing · Form 8-K | -0.30% | -0.18% | |
| Form 10-K Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.41% | +7.67% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -1.41% | +7.67% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 03 | SEC filing · Form 8-K | +1.26% | -4.51% | |
| Form 8-K Cadrenal Therapeutics, For: Feb 04 | SEC filing · Form 8-K | +0.00% | +0.68% | |
| Form S-8 Cadrenal Therapeutics, | SEC filing · Form S-8 | -3.37% | -6.11% | |
| Form S-8 Cadrenal Therapeutics, | SEC filing · Form S-8 | +1.89% | +2.07% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | -0.69% | -11.26% | |
| Form D Cadrenal Therapeutics, | SEC filing · Form D | +0.59% | -1.95% | |
| Form S-3 Cadrenal Therapeutics, | SEC filing · Form S-3 | -3.77% | -9.22% | |
| Form 10-Q Cadrenal Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.37% | +7.58% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -0.58% | -1.27% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 01 | SEC filing · Form 8-K | +1.19% | +2.60% | |
| Form 8-K Cadrenal Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -1.62% | +16.82% | |
| Form 8-K Cadrenal Therapeutics, For: Sep 25 | SEC filing · Form 8-K | -3.34% | -3.91% | |
| Form 8-K Cadrenal Therapeutics, For: Sep 05 | SEC filing · Form 8-K | -3.63% | -2.13% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +2.58% | +23.67% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 16 | SEC filing · Form 8-K | -5.77% | -14.44% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -8.93% | -4.99% | |
| Form 10-Q Cadrenal Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | +11.05% | |
| Form 8-K Cadrenal Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.00% | +5.92% | |
| Form 8-K Cadrenal Therapeutics, For: Jul 29 | SEC filing · Form 8-K | -1.14% | -2.50% | |
| Form DEFA14A Cadrenal Therapeutics, | SEC filing · Form DEFA14A | -4.20% | -3.61% | |
| Form ARS Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | -0.54% | |
| Form DEF 14A Cadrenal Therapeutics, For: Jul 29 | SEC filing · Form DEF | +0.00% | -0.54% | |
| Form PRE 14A Cadrenal Therapeutics, For: May 29 | SEC filing · Form PRE | +3.01% | -0.61% | |
| Form 10-Q Cadrenal Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.21% | +1.13% | |
| Form 8-K Cadrenal Therapeutics, For: May 08 | SEC filing · Form 8-K | +2.21% | +1.13% | |
| Form 8-K Cadrenal Therapeutics, For: Apr 09 | SEC filing · Form 8-K | -4.02% | -28.62% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | -1.16% | -1.98% | |
| Form POS AM Cadrenal Therapeutics, | SEC filing · Form POS | +0.26% | +2.31% | |
| Form EFFECT Cadrenal Therapeutics, | SEC filing · Form EFFECT | -3.02% | +0.16% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +2.37% | -6.74% | |
| Form S-3 Cadrenal Therapeutics, | SEC filing · Form S-3 | +2.37% | -6.74% | |
| Form S-8 Cadrenal Therapeutics, | SEC filing · Form S-8 | +2.37% | -6.74% | |
| Form 10-K Cadrenal Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.30% | +1.37% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +4.30% | +1.37% | |
| Form 8-K Cadrenal Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +10.24% | -0.13% | |
| Form 8-K/A Cadrenal Therapeutics, For: Sep 06 | SEC filing · Form 8-K | -1.10% | -9.29% | |
| Form 8-K Cadrenal Therapeutics, For: Feb 06 | SEC filing · Form 8-K | -0.49% | -4.03% | |
| Form 10-Q Cadrenal Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Cadrenal Therapeutics, For: Nov 09 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Cadrenal Therapeutics, For: Oct 20 | SEC filing · Form 8-K | +3.92% | -2.35% |
Keep exploring
More CVKD: earnings → · analyst actions → · CVKD overview →